Effect of physiotherapy and botulinum toxin injection in treatment of vaginismus

Not Applicable

• Conditions: Psychogenic vaginismus.; Spasm of the pelvic floor muscles that surround the vagina, causing occlusion of the vaginal opening. Penile entry is either impossible or painful

• Registration Number: IRCT2016061828486N1
• Lead Sponsor: Vice Chancellor for research of Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 74

Inclusion Criteria

inclusion criteria:20-40 years old nonpregnant women of sexual health and women clinics of emem khomeini hospital which have grade 3 or 4 vaginismus on lamont grading; they dont have any botulinum toxin containdication( albumin and botulinum or injectable component alergy; infection of injection site; pregnancy; nerve and muscle desease such as Myasthenia Gravis and Lambert Eaton syndrome; coagulation disorders; anticoagulant drugs
exclusion criteria:pregnant women; pregnancy planing; botulinum contraindication; poor cooperation; secondary vaginismus; Vvlvdynya; skin disorders of vulve or Perineum; anal fissure; urinary or deficatory disorders; infection of injection site; previous botulinum treatment; previous physiotherapy

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ibido. Timepoint: before and 1week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).;Arousal. Timepoint: before and 1 week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).;Lubrication. Timepoint: before and 1 week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).;Orgasm. Timepoint: before and 1 week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).;Sexual Satisfaction. Timepoint: before and 1 week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).;Pain. Timepoint: before and 1 week after Treatment. Method of measurement: Demographic questionaries and women sexual function questionaries(FSFI).